🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

JPMorganChase

10 posts
Read More

Thyme Care crosses $2bn valuation as $7bn oncology platform expands into new businesses

Thyme Care has secured more than $125 million from Morgan Health, Humana, CVS Health Ventures and other investors at a valuation above $2 billion. The company is already profitable, reaches 10.5 million people and manages more than $7 billion of oncology spending. Its next move is more ambitious: turning the cancer-care platform into a parent company that can attack drug costs, biosimilar adoption and clinical-trial access.
Read More

Investors put another $1bn into Base Power as home batteries become grid infrastructure

Base Power has raised $1 billion and begun producing its Base Core residential battery in Austin, giving the company fresh capital to expand its distributed energy network across the United States. The valuation reflects growing confidence in virtual power plants, but Base must still prove that its capital-intensive ownership model can generate durable returns at national scale.